BLACAT1 and breast cancer: Recent research reveal that miR-503 can directly bind to and inhibit BLACAT1 (bladder cancer-associated transcript 1), a long non-coding RNA associated with developing chemotherapy resistance in T47D and MCF7 breast cancer cells [70].